Financial reports
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2023 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
28 Feb 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Apr 24
8-K
Other Events
4 Apr 24
8-K
Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year
12 Mar 24
8-K
Clover Health Provides Business Update and Full-Year 2024 Objectives
10 Jan 24
8-K
Departure of Directors or Certain Officers
27 Dec 23
8-K
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
21 Dec 23
8-K
Cost Associated with Exit or Disposal Activities
1 Dec 23
8-K
Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance
6 Nov 23
8-K
Departure of Directors or Certain Officers
3 Nov 23
8-K
Other Events
28 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
28 Mar 24
S-8
Registration of securities for employees
9 Mar 23
S-3
Shelf registration
9 May 22
S-8
Registration of securities for employees
9 Mar 22
S-8
Registration of securities for employees
9 Mar 22
POS AM
Prospectus update (post-effective amendment)
3 Feb 22
POS AM
Prospectus update (post-effective amendment)
2 Feb 22
424B3
Prospectus supplement
19 Jan 22
424B4
Prospectus supplement with pricing info
18 Nov 21
POS EX
Additional exhibits for listing
18 Nov 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Aug 23
DEFA14A
Additional proxy soliciting materials
3 Aug 23
DEF 14A
Definitive proxy
21 Jul 23
DEFA14A
Additional proxy soliciting materials
21 Jul 23
PRE 14A
Preliminary proxy
30 Jun 23
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
2 Sep 22
DEF 14A
Definitive proxy
12 Aug 22
DEFM14A
Proxy related to merger
14 Dec 20
Other
UPLOAD
Letter from SEC
15 Dec 22
CORRESP
Correspondence with SEC
22 Nov 22
UPLOAD
Letter from SEC
9 Nov 22
CORRESP
Correspondence with SEC
28 Sep 22
UPLOAD
Letter from SEC
9 Sep 22
EFFECT
Notice of effectiveness
23 May 22
CORRESP
Correspondence with SEC
18 May 22
UPLOAD
Letter from SEC
13 May 22
EFFECT
Notice of effectiveness
15 Feb 22
EFFECT
Notice of effectiveness
15 Feb 22